Publication | Closed Access

Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer’s disease: Design, synthesis and biological evaluation

Neurodegenerative DiseasesAlzheimer's DiseaseCoumarin-dithiocarbamate HybridsDrug DiscoveryMedicineNovel Multitarget AcheMao-b InhibitorsPharmacological AgentNeuropharmacologyPharmacotherapyDrug DevelopmentPharmacologyBiomolecular Engineering